FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 79 filers reported holding FATE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $152,082 | -22.8% | 31,950 | +217.3% | 0.00% | -90.0% |
| Q4 2019 | $197,000 | +24.7% | 10,070 | -27.7% | 0.01% | -16.7% |
| Q2 2018 | $158,000 | +16.2% | 13,920 | 0.0% | 0.01% | +20.0% |
| Q1 2018 | $136,000 | +60.0% | 13,920 | 0.0% | 0.01% | +66.7% |
| Q4 2017 | $85,000 | +54.5% | 13,920 | 0.0% | 0.01% | +50.0% |
| Q3 2017 | $55,000 | -12.7% | 13,920 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $63,000 | – | 13,920 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |